UNSPSC 51102907: Amodiaquine/artesunate

This classification is for a combination antimalarial drug. The first component, AMODIAQUINE, has a US FDA Unique Ingredient Identifier of 220236ED28. The second component, ARTESUNATE, has a US FDA Unique Ingredient Identifier of 60W3249T9M.

UNSPSC 51102907 Amodiaquine/artesunate, a Commodity code, shows no relevant recent state and local procurement activity. The recent opportunities tagged under this code—including a county purchasing department relocation notice, a Florida county's naloxone and drug deactivation systems procurement, a Tucson Fire Department BLS/ALS pharmaceuticals and vending machine solicitation, a Minnesota multistate cooperative generic pharmaceuticals RFP, vendor networking events, and a Pinellas County forensic drug standards procurement—do not align with antimalarial pharmaceutical procurement. The mismatch between the code's nominal scope (amodiaquine/artesunate, treatments for malaria) and the actual opportunities posted (emergency medical supplies, naloxone, generic pharmaceuticals, forensic reference materials, and networking forums) indicates that either the code is misapplied to these notices or state and local governments are not actively soliciting this specific commodity.

State and local procurement for antimalarial drugs does not appear in the recent activity block. When pursuing this code, expect to find demand primarily through health departments, public hospitals, and tropical disease clinics in states with endemic or at-risk populations; however, no current solicitations demonstrate active procurement of amodiaquine/artesunate or related combination therapies. Watching this code requires monitoring health department and public health authority notices in Florida, Louisiana, Texas, and other states with higher malaria exposure risk, as well as any cooperative purchasing vehicles that serve public health systems, rather than relying on the recent notices posted under this UNSPSC classification.